Trials / Completed
CompletedNCT00446186
MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)
Mk0476 Phase II Dose Finding Study -Allergic Rhinitis-
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 945 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The clinical study evaluates the efficacy and safety of MK0476 in adult patients with allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, montelukast sodium / Duration of Treatment: 2 Weeks | |
| DRUG | Comparator: placebo / Duration of Treatment: 2 Weeks |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2004-03-01
- Completion
- 2004-03-01
- First posted
- 2007-03-12
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00446186. Inclusion in this directory is not an endorsement.